BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3460297)

  • 41. Neurotensin increases intestinal adaptation and reduces enteroglucagon-like immunoreactivity after large bowel resection in rats.
    Mata A; Gómez de Segura IA; Largo C; Codesal J; De Miguel E
    Eur J Surg; 1997 May; 163(5):387-93. PubMed ID: 9195173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum.
    Krag E; Phillips SF
    J Clin Invest; 1974 Jun; 53(6):1686-94. PubMed ID: 4830231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport.
    Ockner RK; Manning JA
    J Clin Invest; 1974 Aug; 54(2):326-38. PubMed ID: 4211161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of intraduodenal installation of oleic acid on plasma neurotensin-like immunoreactivity and on gastric acid secretion stimulated by betazole and sham feeding in man.
    Kihl B; Rökaeus A; Rosell S; Olbe L
    Scand J Gastroenterol; 1982 Aug; 17(5):633-9. PubMed ID: 7178827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of a rat isolated ileal preparation to investigate the release of neurotensin.
    Gill SS; Lee YC; Ghatei MA; Ghiglione M; Uttenthal LO; Bloom SR
    Clin Exp Pharmacol Physiol; 1984; 11(5):457-65. PubMed ID: 6525764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fatty acids stereospecifically stimulate neurotensin release and increase [Ca2+]i in enteric endocrine cells.
    Barber DL; Cacace AM; Raucci DT; Ganz MB
    Am J Physiol; 1991 Sep; 261(3 Pt 1):G497-503. PubMed ID: 1887896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The regional distribution of neurotensin-like immunoreactivity in central and peripheral tissues of the cat.
    Goedert M; Emson PC
    Brain Res; 1983 Aug; 272(2):291-7. PubMed ID: 6616204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rates of small intestinal mucosal protein synthesis in human jejunum and ileum.
    Nakshabendi IM; McKee R; Downie S; Russell RI; Rennie MJ
    Am J Physiol; 1999 Dec; 277(6):E1028-31. PubMed ID: 10600791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of renal failure or portacaval shunt on release of neurotensin in man.
    Eaves ER; Hansky J
    Dig Dis Sci; 1987 Jan; 32(1):28-32. PubMed ID: 3792180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurotensin-like immunoreactivity released into the portal vein by duodenal acidification in the dog.
    Mogard M; Böttcher W; Kauffman GL; Washington J; Walsh JH
    Scand J Gastroenterol; 1986 Jan; 21(1):97-103. PubMed ID: 3081992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intestinal intraluminal continuity is a prerequisite for the distal bowel motility response to feeding.
    Hallgren T; Oresland T; Cantor P; Fasth S; Hultén L
    Scand J Gastroenterol; 1995 Jun; 30(6):554-61. PubMed ID: 7569763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Release of neurotensin-like immunoreactivity (NTLI) from the gut in anaesthetized dogs.
    Mashford ML; Nilsson G; Rökaeus A; Rosell S
    Acta Physiol Scand; 1978 Nov; 104(3):375-6. PubMed ID: 716989
    [No Abstract]   [Full Text] [Related]  

  • 53. Ontogenic development of neurotensin-like immunoreactivity in the gastrointestinal tract and the influence of dietary changes in rats.
    Muraki K; Nishi Y; Okahata H; Arai M; Yamada H; Fujita S; Miyachi Y; Ueda K
    J Pediatr Gastroenterol Nutr; 1987; 6(2):290-5. PubMed ID: 3694352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspects of neurotensin physiology and pathology.
    Bloom SR; Polak JM
    Ann N Y Acad Sci; 1982; 400():105-16. PubMed ID: 6963109
    [No Abstract]   [Full Text] [Related]  

  • 55. Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry.
    Polak JM; Sullivan SN; Bloom SR; Buchan AM; Facer P; Brown MR; Pearse AG
    Nature; 1977 Nov; 270(5633):183-4. PubMed ID: 337160
    [No Abstract]   [Full Text] [Related]  

  • 56. Concentration of neurotensin in human plasma after glucose, meals and lipids.
    Flaten O; Hanssen LE
    Acta Physiol Scand; 1982 Feb; 114(2):311-3. PubMed ID: 7136762
    [No Abstract]   [Full Text] [Related]  

  • 57. Chromatographic characterisation of neurotensin-like immunoreactivity in plasma and tissue extracts from hepatoma patients.
    Lee YC; Bacarese-Hamilton AJ; Wood SM; Blumgart LH; Bloom SR
    Clin Chim Acta; 1985 Jun; 149(1):29-36. PubMed ID: 2992844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of nutrients in the gastrointestinal release of immunoreactive neurotensin.
    Go VL; Demol P
    Peptides; 1981; 2 Suppl 2():267-9. PubMed ID: 7343962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single- and double-peak phenomena in the plasma profiles.
    Charman WN; Rogge MC; Boddy AW; Barr WH; Berger BM
    J Clin Pharmacol; 1993 Dec; 33(12):1207-13. PubMed ID: 8126256
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.